H.R. 796

119th CONGRESS 1st Session

To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES · January 28, 2025 · Sponsor: Mrs. Miller of Illinois · Committee: Committee on Energy and Commerce

Table of contents

• H.R. 796
  • SEC. 1. Short title
  • SEC. 2. Mifepristone warning label and hotline

SEC. 1. Short title

• This Act may be cited as the Second Chance for Moms Act.

SEC. 2. Mifepristone warning label and hotline

• (a) Warning label
  • (1) In general
    • Section 502 of the Federal Food, Drug, and Cosmetic Act () is amended by adding at the end the following: 21 U.S.C. 352
      • If it is the drug mifepristone, and its labeling does not bear the following statement printed in conspicuous text: (with the blank filled in to refer to the appropriate number for the hotline under section 1009 of the Public Health Service Act). WARNING: Medical evidence suggests that the abortifacient effects of mifepristone can be counteracted by natural progesterone, which can increase the chance of fetal survival. The American Society for Reproductive Medicine has determined that natural progesterone is safe in the first trimester of pregnancy. For more information, call [___].
  • (2) Effective date
    • Section 502(hh) of the Federal Food, Drug, and Cosmetic Act (as added by paragraph (1)) applies beginning on the date that is 6 months after the date of enactment of this Act.
• (b) Hotline
  • Title X of the Public Health Service Act () is amended by adding at the end the following: 42 U.S.C. 300 et seq.
    • (a) In general
      • The Secretary shall establish or maintain, directly or by grant or contract, a toll-free hotline to provide support for 24 hours a day, 7 days a week, for women seeking to reverse the effects of the drug mifepristone.
    • (b) Referrals to APR providers only
      • A referral through the hotline described in subsection (a) may only be made to a health care provider that provides abortion pill reversal services.